Methylene blue and the neurotoxic mechanisms of ifosfamide encephalopathy A. KüpferC. AeschlimannT. Cerny MINI REVIEW Pages: 249 - 252
What happens to long-term medication when general practice patients are referred to hospital? W. HimmelM. TabacheM. M. Kochen PHARMACODEPIDEMIOLOGY AND PRESCRIPTION Pages: 253 - 257
Evaluation of the antihypertensive efficacy and tolerability of moexipril, a new ACE inhibitor, compared to hydrochlorothiazide in elderly patients B. PerssonM. Stimpel PHARMACODYNAMICS Pages: 259 - 264
Dose-finding study of imidapril, a novel angiotensin converting enzyme inhibitor, in patients with stable chronic heart failure Y. M. PintoD. J. van VeldhuisenK. I. Lie PHARMACODYNAMICS Pages: 265 - 268
Reproducibility of airway response to inhaled bradykinin and effect of the neurokinin receptor antagonist FK-24 in asthmatic subjects D. SchmidtR. A. JörresH. Magnussen PHARMACODYNAMICS Pages: 269 - 273
Effects of short-term exposure to high-dose inhaled corticosteroids on novel markers of bone metabolism A. GroveL. C. McFarlaneB. J. Lipworth PHARMACODYNAMICS Pages: 275 - 277
Digital pulse plethysmography as a non-invasive method for predicting drug-induced changes in left ventricular preload E. StengeleF. WinklerH. Roskamm PHARMACODYNAMICS Pages: 279 - 282
Stereoselective distribution of tiaprofenic acid in synovium and cartilage in osteoarthritic patients F. LapicqueD. MainardP. Netter PHARMACOKINETICS AND DISPOSITION Pages: 283 - 287
Pharmacokinetics of flosequinan in patients with heart failure D. P. NichollsA. DrooganI. D. Hind PHARMACOKINETICS AND DISPOSITION Pages: 289 - 291
Pharmacokinetics and absolute bioavailability of lansoprazole J. GerloffA. MignotK. Heintze PHARMACOKINETICS AND DISPOSITION Pages: 293 - 297
Comparison of the pharmacokinetics of tirilazad mesylate in healthy volunteers and stable subjects with mild liver cirrhosis L. K. PearsonJ. C. FleishakerG. R. Peters PHARMACOKINETICS AND DISPOSITION Pages: 299 - 304
Effect of moderate or severe liver dysfunction on the pharmacokinetics of γ-hydroxybutyric acid S. D. FerraraL. TedeschiP. Palatini PHARMACOKINETICS AND DISPOSITION Pages: 305 - 310
Effect of food intake on pharmacokinetics and effects of a new thromboxane A2 receptor antagonist, S-1452 A. FujimuraT. ShigaT. Kotegawa PHARMACOKINETICS AND DISPOSITION Pages: 311 - 314
Influence of food on the bioavailability and some pharmacokinetic parameters of diprafenone – a novel antiarrhythmic agent R. KoytchevR.-G. AlkenM. Greenwood PHARMACOKINETICS AND DISPOSITION Pages: 315 - 319
Absolute bioavailability of fluoride from disodium monofluorophosphate and enteric-coated sodium fluoride tablets P. van AstenS. A. DuursmaA. van Dijk PHARMACOKINETICS AND DISPOSITION Pages: 321 - 326
Plasma and skin suction-blister-fluid pharmacokinetics and time course of the effects of oral mizolastine O. ChosidowC. DubrucJ. Revuz PHARMACOKINETICS AND DISPOSITION Pages: 327 - 333
A single dose of ursodiol does not affect cyclosporine absorption in liver transplant patients C. W. MaboundouG. PaintaudP. R. Bechtel PHARMACOKINETICS AND DISPOSITION Pages: 335 - 337
Exercise increases plasma concentrations of (R)- and (S)-propranolol K. StoschitzkyM. SchumacherW. Lindner PHARMACOKINETICS AND DISPOSITION Pages: 339 - 342